Company CVAbout Vivo Bio Tech Ltd. 
Vivo Bio Tech Ltd.
Micro Cap
Pharmaceuticals & Drugs
Vivo Bio Tech Limited, established in February, 1987 is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies etc. Their experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules.
Company Coordinates
Company Details
Survey #349/A Pregnapur Vlge , Gajel Telangana : 502311
Registrar Details
Aarthi Consultants Pvt Ltd, 1-2-285 , Domalaguda, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 14.90 Cr
Number of Shares
1.49 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
04-Jan-2023
1.49
14.90
27000
10
Issued under ESOP Scheme
06-May-2022
1.49
14.88
613000
10
Conversion of Warrants
02-Feb-2022
1.43
14.26
59000
10
Issued under ESOP Scheme
31-May-2021
1.42
14.20
210000
10
Conversion of Warrants
06-May-2021
1.4
13.99
130000
10
Issued under ESOP Scheme
23-Apr-2021
1.39
13.86
230000
10
Conversion of Warrants
16-Apr-2021
1.36
13.63
215000
10
Conversion of Warrants
31-Mar-2021
1.34
13.42
150000
10
Preferential issue/warr.conversion
26-Mar-2021
1.33
13.27
382000
10
Conversion of Warrants
23-Oct-2019
1.29
12.89
137000
10
Issued under ESOP Scheme
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Cryptologic Systems Private Limited (7.97%)
Highest Public shareholder
Elite Class Asset Holdings Ltd (7.71%)
Individual Investors Holdings
33.5%
Board of Directors
Management
Designation
Remuneration
Kalyan Ram Mangipudi
Whole-time Director
8.61 lacs
Alangudi Sankaranarayanan
Whole-time Director
3.47 lacs
K Sunder
Chairman & Independent Directo
1.8 lacs
Hariharan Ravindran
Independent Director
1.15 lacs
Kunda Kalpana
Independent Director
1.8 lacs
Karopadi Shivanand Nayak
Director
80.0 k
K Sri Kalyan
Whole Time Director & CFO
3.7 lacs
Shyam Sunder Tipparaju
Additional Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Income from Pharmaceuticals Services
47.00
100.00%
Income from Pharmaceuticals Services
Stock DNARevenue and Profits:
Net Sales:
12 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
Pharmaceuticals & Drugs
INR 59 Cr (Micro Cap)
8.00
33
0.00%
0.95
12.47%
0.98
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
